Cargando…
Comparison of external system and implanted system in intrathecal therapy for refractory cancer pain in China: A retrospective study
INTRODUCTION: Intrathecal therapy (ITT) via an implanted system was demonstrated for the treatment of refractory cancer pain for decades. Recently, the dissemination of ITT is enhanced in an external system way in Asia for a lower implantation cost. This study compares the efficacy, safety, and cost...
Autores principales: | Qin, Wangjun, Zhao, Li, Liu, Botao, Yang, Yang, Mao, Peng, Xu, Liyuan, Li, Pengmei, Shang, Yongguang, Zhang, Lei, Fan, Bifa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847588/ https://www.ncbi.nlm.nih.gov/pubmed/36545706 http://dx.doi.org/10.1002/brb3.2851 |
Ejemplares similares
-
Intrathecal Morphine Infusion Therapy via a Percutaneous Port for Refractory Cancer Pain in China: An Efficacy, Safety and Cost Utilization Analysis
por: Qin, Wangjun, et al.
Publicado: (2020) -
Pain Physicians’ Attitudes and Experiences Regarding Clinical Pharmacy Services in China: A National Cross-Sectional Survey
por: Qin, Wangjun, et al.
Publicado: (2023) -
The prevalence and management of chronic pain in the Chinese population: findings from the China Pain Health Index (2020)
por: Jiang, Yingying, et al.
Publicado: (2022) -
Super analgesia of intrathecal morphine may be related to ABCB1 (MDR1) gene polymorphism
por: Qin, Wangjun, et al.
Publicado: (2018) -
Management of refractory chronic pain in sickle cell disease with intrathecal drug delivery system
por: Mendes, Plinio Duarte, et al.
Publicado: (2023)